1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSolicits applications for randomized controlled clinical trials on long-term effects of nutritional interventions on age-related chronic conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities and research institutions. Confirm the full requirements in the official notice before applying.
The published deadline was September 25, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Controlled Clinical Trials on Long-Term Effects of Nutritional Interventions on the Progression of Risk Factors for Age-Related Chronic Conditions is funded by National Institutes of Health. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Broad Pragmatic Studies PCORI Funding Announcement – Cycle 2 2026 is a grant from the Patient-Centered Outcomes Research Institute that funds large-scale, high-impact patient-centered comparative clinical effectiveness research (CER). PCORI invites proposals for pragmatic randomized controlled trials, natural experiments, and well-designed observational studies that address clinically meaningful outcomes important to patients. Awards reach up to $12,000,000 in direct costs for Categories 2-3, and up to $5,000,000 for Category 1. Proposals must align with PCORI's Foundational Expectations for Partnerships in Research. The Letter of Intent deadline is April 28, 2026, and the full application deadline is September 1, 2026.
Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). This program funds small businesses to conduct research and development with commercial potential in health-related technologies. It supports early feasibility through later-stage commercialization.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article